Anumana Makes Educated Inferences in Heart Failure

Anumana was founded in 2021 as the culmination of a joint effort between the Mayo Clinic and nference, an early entrant to the field of machine learning for cardiology-focused clinical solutions. By leveraging large stores of deidentified data that span full patient journeys from physician notes to medications and imaging files, Anumana develops cardiac AI-based solutions that can glean pertinent disease information from electrocardiogram (ECG)waveforms. The company’s first FDA-cleared cardiac ECG-AI algorithm detects low ejection fraction (LEF), and two additional algorithms for pulmonary hypertension and cardiac amyloidosis are under review.

Read the Article in MedTech Strategist